All this “frenetic” activity result? A handful of sales per quarter. $10 mill cash burn year in, year out.
And a failed business model that no one wants to buy. No one. Just pure crap. Period.
- Forums
- ASX - By Stock
- OSL
- Ann: Two more PANCOSIL Trial treatments using OncoSil device
Ann: Two more PANCOSIL Trial treatments using OncoSil device, page-226
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
-0.001(11.1%) |
Mkt cap ! $35.79M |
Open | High | Low | Value | Volume |
0.9¢ | 0.9¢ | 0.8¢ | $57.81K | 6.814M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2730736 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 10051301 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2730736 | 0.008 |
65 | 29450848 | 0.007 |
20 | 16512999 | 0.006 |
19 | 8310198 | 0.005 |
8 | 6548488 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 10051301 | 11 |
0.010 | 11757583 | 13 |
0.011 | 11684301 | 17 |
0.012 | 7560752 | 5 |
0.013 | 5000000 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online